Howard A. "Skip" Burris, III
M.D.

Dr. Burris serves as president and chief medical officer of Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. At SCRI, he has focused on the development of new cancer agents with an emphasis on first-in-human therapies, having led the trials of many novel antibodies, small molecules and chemotherapies that are now approved by the U.S. Food and Drug Administration and have changed the standard of care for several types of cancers. As a well-respected key opinion leader globally, Dr. Burris was elected by his peers to serve as the president of the American Society of Clinical Oncology (ASCO) and has continued to hold several leadership positions on behalf of the ASCO community. Prior to his term as president, Dr. Burris served in a variety of leadership roles over many years, including the ASCO Board of Governors, the ASCO Audit Committee and as chair of the ASCO Nominating Committee. Currently, he is chair of the Board for the ASCO Conquer Cancer Foundation.

Dr. Burris received his undergraduate degree at West Point and his medical degree from the University of South Alabama. He performed his residency and fellowship in hematology/oncology at Brooke Army Medical Center in San Antonio.